2019
DOI: 10.1016/j.cca.2019.05.014
|View full text |Cite
|
Sign up to set email alerts
|

Substance P in cardiovascular diseases – A bioanalytical review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 18 publications
(10 citation statements)
references
References 56 publications
0
9
0
Order By: Relevance
“…In particular, SP influences cardiomyocyte activity through the activation of cholinergic innervation and causes bradycardia [55,56]. Moreover, SP regulates the blood flow in vessels located in the heart wall (the character of this impact depends on gender) [57,58] and may stimulate the growth of cardiomyocytes [59] and influence the heart mast cells, stimulating the release of pro-inflammatory factors [60][61][62]. It is also known that SP participates in mechanisms connected with various heart diseases, including viral and parasitic infections, heart ischemia and cardiac fibrosis [54,59].…”
Section: Discussionmentioning
confidence: 99%
“…In particular, SP influences cardiomyocyte activity through the activation of cholinergic innervation and causes bradycardia [55,56]. Moreover, SP regulates the blood flow in vessels located in the heart wall (the character of this impact depends on gender) [57,58] and may stimulate the growth of cardiomyocytes [59] and influence the heart mast cells, stimulating the release of pro-inflammatory factors [60][61][62]. It is also known that SP participates in mechanisms connected with various heart diseases, including viral and parasitic infections, heart ischemia and cardiac fibrosis [54,59].…”
Section: Discussionmentioning
confidence: 99%
“…The discrepancy between these failures and promising preclinical studies leads to the assumption that the roles of the tachykinins are not fully understood until now [5]. This lack of knowledge may be based on the high variability of SP blood levels caused by distinct analytical techniques and sample preparation methods [6][7][8]. The determination of SP and HK-1 blood levels are predominantly executed by immunoassays, which often lack the required selectivity to differentiate between SP and HK-1 due to crossreactivity [9,10].…”
Section: Rpkpqqffglm-nh2mentioning
confidence: 99%
“…As SP and HK-1 are positively charged and moderately hydrophobic peptides (Table 1), they unify the potential to adsorb to glass as well as plastic surfaces [14][15][16]. Due to their low concentrations in picomolar ranges in plasma samples [8], adsorption processes are highly critical and play an essential role during accurate sample preparation and measurement. Moreover, the phenomenon of adsorption may lead to an underestimation of peptide levels in the case of biomarker assays and subsequently results in incorrect conclusions of biomarker levels and poor comparability between different studies [17,18].…”
Section: Rpkpqqffglm-nh2mentioning
confidence: 99%
See 2 more Smart Citations